Share ownership Chongqing Zhifei Biological Products Co., Ltd.
Equities
300122
CNE100000V20
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 25.40 CNY | +3.04% |
|
+5.44% | -3.42% |
| Dec. 09 | Chongqing Zhifei Biological, GSK Adjust Terms of Cooperation Agreement | MT |
| Dec. 05 | GSK, China's Zhifei Extend Shingles Shot Collaboration to 2034 | DJ |
Share class: Chongqing Zhifei Biological Products Co., Ltd.
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 2,393,789,747 | 353,427,644 ( 14.76 %) | 0 | 14.76 % |
Major shareholders: Chongqing Zhifei Biological Products Co., Ltd.
| Name | Equities | % | Valuation |
|---|---|---|---|
Ren Sheng Jiang
20.41
%
| 289,893,375 | 20.41 % | 1 045 M ¥ |
Tie Ying Liu
6.441
%
| 91,500,000 | 6.441 % | 330 M ¥ |
Ling Feng Jiang
2.281
%
| 32,400,000 | 2.281 % | 117 M ¥ |
China Merchants Fund Management Co., Ltd.
2.252
%
| 31,989,733 | 2.252 % | 115 M ¥ |
China Merchants Wealth Asset Management Ltd.
1.476
%
| 20,962,975 | 1.476 % | 76 M ¥ |
China Construction Bank Corp.
1.335
%
| 18,956,936 | 1.335 % | 68 M ¥ |
Guan Jiang Wu
1.249
%
| 17,738,657 | 1.249 % | 64 M ¥ |
Shanghai Yingshui Investment Management Co. Ltd.
1.237
%
| 17,575,500 | 1.237 % | 63 M ¥ |
Huatai-PineBridge Fund Management Co., Ltd.
1.071
%
| 15,210,624 | 1.071 % | 55 M ¥ |
Tian Hong Asset Management Co., Ltd.
0.8747
%
| 12,424,870 | 0.8747 % | 45 M ¥ |
| ░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
| ░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
| ░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
| ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
| ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
| ░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
| ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
| ░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
| ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
| ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
| ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
| ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
| ░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
| ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
| ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
| Name | Equities | % | Valuation |
|---|---|---|---|
Ren Sheng Jiang
88.79
%
| 869,680,125 | 88.79 % | 3 134 M ¥ |
Ling Feng Jiang
9.924
%
| 97,200,000 | 9.924 % | 350 M ¥ |
Xi Sheng Jiang
1.286
%
| 12,600,000 | 1.286 % | 45 M ¥ |
Breakdown by shareholder type
| Individuals | 30.67% |
| Institutional | 14.13% |
| China Construction Bank Corp. | 1.33% |
| Other | 1.24% |
| Unknown | 52.63% |
Based on 1000 largest holdings
Geographical origin of shareholders
| Individuals | 30.68% |
| China | 16.52% |
| Hong Kong | 0.08% |
| Sweden | 0.03% |
| United Kingdom | 0.02% |
| Ireland | 0.02% |
| Switzerland | 0.01% |
Based on 1000 largest holdings
Employees
6,545
Sector
Pharmaceuticals
Calendar
2025-04-15
- Q1 2025 Earnings Release (Projected)